Document_and_Entity_Informatio
Document and Entity Information (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Mar. 18, 2014 | Jun. 30, 2013 | |
Document And Entity Information | ' | ' | ' |
Entity Registrant Name | 'MamaMancini's Holdings, Inc. | ' | ' |
Entity Central Index Key | '0001520358 | ' | ' |
Document Type | '10-K | ' | ' |
Document Period End Date | 31-Dec-13 | ' | ' |
Amendment Flag | 'false | ' | ' |
Current Fiscal Year End Date | '--12-31 | ' | ' |
Entity Well-known Seasoned Issuer | 'No | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Filer Category | 'Smaller Reporting Company | ' | ' |
Entity Public Float | ' | ' | $12,524,616 |
Entity Common Stock, Shares Outstanding | ' | 25,257,374 | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
Document Fiscal Year Focus | '2013 | ' | ' |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
Assets: | ' | ' |
Cash | $1,741,935 | $2,008,161 |
Accounts receivable, net | 1,063,849 | 463,565 |
Inventories | 112,279 | 76,570 |
Prepaid expenses | 135,525 | 64,178 |
Due from manufacturer - related party | 781,521 | 159,200 |
Deposit with manufacturer - related party | 359,506 | 192,956 |
Total current assets | 4,194,615 | 2,964,630 |
Property and equipment, net | 929,496 | 17,451 |
Total Assets | 5,124,111 | 2,982,081 |
Liabilities: | ' | ' |
Accounts payable and accrued expenses | 823,044 | 329,233 |
Line of credit | ' | 200,000 |
Total current liabilities | 823,044 | 529,233 |
Commitments and contingencies | ' | ' |
Stockholders' Equity | ' | ' |
Preferred stock, $0.00001 par value; 20,000,000 shares authorized; no shares issued and outstanding | ' | ' |
Common stock, $0.00001 par value; 250,000,000 shares authorized; 24,187,375 and 20,054,000 shares issued and outstanding, respectively | 242 | 201 |
Additional paid in capital | 10,600,461 | 5,804,680 |
Common stock subscribed; 533,333 shares | 5 | ' |
Accumulated deficit | -6,299,641 | -3,352,033 |
Total Stockholders' Equity | 4,301,067 | 2,452,848 |
Total Liabilities and Stockholders' Equity | $5,124,111 | $2,982,081 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parenthetical) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
Statement of Financial Position [Abstract] | ' | ' |
Preferred stock, par value | $0.00 | $0.00 |
Preferred stock, shares authorized | 20,000,000 | 20,000,000 |
Preferred stock, shares issued | ' | ' |
Preferred stock, shares outstanding | ' | ' |
Common stock, par value | $0.00 | $0.00 |
Common stock, shares authorized | 250,000,000 | 250,000,000 |
Common stock, shares issued | 24,187,375 | 20,054,000 |
Common stock, shares outstanding | 24,187,375 | 20,054,000 |
Common stock subscribed, shares | 533,333 | ' |
Consolidated_Statements_of_Ope
Consolidated Statements of Operations (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Income Statement [Abstract] | ' | ' |
Sales - net of slotting fees and discounts | $8,741,621 | $4,582,845 |
Cost of sales | 6,190,595 | 3,230,589 |
Gross profit | 2,551,026 | 1,352,256 |
Operating expenses | ' | ' |
Research and development | 19,408 | 68,372 |
General and administrative expenses | 5,470,586 | 3,271,160 |
Total operating Expenses | 5,489,994 | 3,339,532 |
Loss from operations | -2,938,968 | -1,987,276 |
Other income (expenses) | ' | ' |
Interest expense | -8,640 | -12,347 |
Total other income (expense) | -8,640 | -12,347 |
Net loss | ($2,947,608) | ($1,999,623) |
Net loss per common share - basic and diluted | ($0.13) | ($0.12) |
Weighted average common shares outstanding - basic and diluted | 22,012,920 | 17,358,333 |
Consolidated_Statement_of_Chan
Consolidated Statement of Changes in Stockholders' Equity (USD $) | Common Stock [Member] | Additional Paid-In Capital [Member] | Common Stock Subscribed [Member] | Accumulated Deficit [Member] | Total |
Balance at Dec. 31, 2011 | $150 | $1,401,573 | ' | ($1,352,410) | $49,313 |
Balance, shares at Dec. 31, 2011 | 15,000,000 | ' | ' | ' | ' |
Common stock issued for cash | 51 | 5,053,949 | ' | ' | 5,054,000 |
Common stock issued for cash, shares | 5,054,000 | ' | ' | ' | 5,054,000 |
Warrants issued for services | ' | 438,122 | ' | ' | 438,122 |
Stock issuance costs | ' | -1,088,964 | ' | ' | -1,088,964 |
Net loss | ' | ' | ' | -1,999,623 | -1,999,623 |
Balance at Dec. 31, 2012 | 201 | 5,804,680 | ' | -3,352,033 | 2,452,848 |
Balance, shares at Dec. 31, 2012 | 20,054,000 | ' | ' | ' | ' |
Common stock issued for cash | 33 | 4,999,967 | ' | ' | 5,000,000 |
Common stock issued for cash, shares | 3,333,375 | ' | ' | ' | ' |
Common stock subscribed , 533,333 shares | ' | 799,995 | 5 | ' | 800,000 |
Recapitalization | 8 | -295,008 | ' | ' | -295,000 |
Recapitalization, shares | 800,000 | ' | ' | ' | ' |
Stock options issued for services | ' | 162,933 | ' | ' | 162,933 |
Warrants issued for services | ' | 731,894 | ' | ' | 731,894 |
Stock issuance costs | ' | -1,604,000 | ' | ' | -1,604,000 |
Net loss | ' | ' | ' | -2,947,608 | -2,947,608 |
Balance at Dec. 31, 2013 | $242 | $10,600,461 | $5 | ($6,299,641) | $4,301,067 |
Balance, shares at Dec. 31, 2013 | 24,187,375 | ' | ' | ' | ' |
Consolidated_Statement_of_Chan1
Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) | Dec. 31, 2013 | Dec. 31, 2012 |
Statement of Stockholders' Equity [Abstract] | ' | ' |
Common stock subscribed, shares | 533,333 | ' |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ' | ' |
Net loss | ($2,947,608) | ($1,999,623) |
Adjustments to reconcile net loss to net cash used in operating activities: | ' | ' |
Depreciation | 33,891 | 12,564 |
Share-based compensation | 162,933 | ' |
Loss on disposition of fixed assets | 15,343 | ' |
(Increase) Decrease in: | ' | ' |
Accounts receivable | -600,284 | 117,914 |
Inventory | -35,709 | 24,540 |
Prepaid expenses | -71,347 | 23,492 |
Due from manufacturer - related party | -622,321 | -159,200 |
Deposit with manufacturer - related party | -166,550 | -90,096 |
Increase (Decrease) in: | ' | ' |
Accounts payable and accrued expenses | 410,054 | 46,739 |
Due to manufacturer - related party | ' | -69,544 |
Net Cash Used In Operating Activities | -3,821,598 | -2,093,214 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ' | ' |
Cash paid for machinery and equipment | -877,522 | -10,000 |
Deposits on property and equipment | ' | -8,288 |
Cash paid for acquisition of shell company | -295,000 | ' |
Loans to related party | -30,000 | ' |
Related party loans repaid | 30,000 | ' |
Net Cash Used In Investing Activities | -1,172,522 | -18,288 |
CASH FLOWS FROM FINANCING ACTIVITIES: | ' | ' |
Proceeds from issuance of common stock | 5,000,000 | 5,054,000 |
Stock issuance costs | -872,106 | -650,842 |
Proceeds from common stock subscribed | 800,000 | ' |
Proceeds from credit line | 150,000 | ' |
Repayment of credit line | -350,000 | -300,000 |
Net Cash Provided By Financing Activities | 4,727,894 | 4,103,158 |
Net Increase (Decrease) in Cash | -266,226 | 1,991,656 |
Cash - Beginning of Period | 2,008,161 | 16,505 |
Cash - End of Period | 1,741,935 | 2,008,161 |
Cash Paid During the Period for: | ' | ' |
Income taxes | ' | ' |
Interest | 8,640 | 12,347 |
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING | ' | ' |
Stock issuance costs paid in the form of warrants | 731,894 | 438,122 |
Machinery and equipment purchased on account | $83,757 | ' |
Nature_of_Operations_and_Basis
Nature of Operations and Basis of Presentation | 12 Months Ended |
Dec. 31, 2013 | |
Nature Of Operations And Basis Of Presentation | ' |
Nature of Operations and Basis of Presentation | ' |
Note 1 - Nature of Operations and Basis of Presentation | |
Nature of Operations | |
MamaMancini’s Holdings, Inc. (the “Company”), (formerly known as Mascot Properties, Inc.) was organized on July 22, 2009 as a Nevada corporation. | |
Current Business of the Company | |
The Company is a manufacturer and distributor of a line of beef meatballs with sauce, turkey meatballs with sauce, Italian sausage with sauce and other similar Italian meats with sauces. The Company’s customers are located throughout the United States, with a large concentration in the Northeastern and Southeastern United States regions. | |
Mergers | |
On January 24, 2013, the Company, Mascot Properties Acquisition Corp, a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”), MamaMancini’s, Inc., a privately-held Delaware Corporation headquartered in New Jersey (“MamaMancini’s”) and an individual (the “Majority Shareholder”), entered into an Acquisition Agreement and Plan of Merger (the “Agreement”) pursuant to which the Merger Sub was merged with and into MamaMancini’s, with MamaMancini’s surviving as a wholly-owned subsidiary of the Company (the “Merger”). The Company acquired, through a reverse triangular merger, all of the outstanding capital stock of MamaMancini’s in exchange for issuing MamaMancini’s shareholders (the “MamaMancini’s Shareholders”), pro-rata, a total of 20,054,000 shares of the Company’s common stock. Immediately after the Merger was consummated, and further to the Agreement, the majority shareholders and certain affiliates of the Company cancelled a total of 103,408,000 shares of the Company’s common stock held by them (the “Cancellation”). In consideration of the Cancellation of such common stock, the Company paid the Majority Shareholder in aggregate of $295,000 and 800,000 shares of common stock and released the other affiliates from certain liabilities. In addition, the Company has agreed to spin out to the Majority Shareholder all assets related to the Company’s real estate management business within 30 days after the closing. As a result of the Merger and the Cancellation, the MamaMancini’s Shareholders became the majority shareholders of the Company. | |
The consolidated financial statements presented for all periods through and including December 31, 2013 are those of MamaMancini’s. As a result of this Merger, the equity sections of MamaMancini’s for all prior periods presented reflect the recapitalization described above and are consistent with the December 31, 2013 balance sheet presented for the Company. | |
Since the transaction is considered a reverse acquisition and recapitalization, the presentation of pro-forma financial information was not required. | |
Basis of Presentation | |
The consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation. |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Accounting Policies [Abstract] | ' | ||||||||
Summary of Significant Accounting Policies | ' | ||||||||
Note 2 - Summary of Significant Accounting Policies | |||||||||
Principles of consolidation | |||||||||
All significant intercompany accounts and transactions have been eliminated in consolidation. | |||||||||
Use of estimates | |||||||||
The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for bad debt, inventory obsolescence, the fair value of share-based payments. | |||||||||
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates. | |||||||||
Risks and uncertainties | |||||||||
The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure. | |||||||||
The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including the general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis. | |||||||||
Cash | |||||||||
The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at December 31, 2013 and December 31, 2012. | |||||||||
The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. | |||||||||
Accounts receivable and allowance for doubtful accounts | |||||||||
Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of December 31, 2013 and 2012, the Company had reserves of $2,000. | |||||||||
Inventories | |||||||||
Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at December 31, 2013 and 2012: | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Finished goods | $ | 112,279 | $ | 76,570 | |||||
Property and Equipment | |||||||||
Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives. | |||||||||
Asset lives for financial statement reporting of depreciation are: | |||||||||
Machinery and equipment | 2-7 years | ||||||||
Vehicles | 3-5 years | ||||||||
Fair Value of Financial Instruments | |||||||||
For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short term financial instruments approximates fair value due to the relatively short period to maturity for these instruments. | |||||||||
Stock Issuance Costs | |||||||||
Stock Issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity. Offering costs recorded to equity for the years ended December 31, 2013 and 2012 were$1,604,000 and $1,088,964, respectively. | |||||||||
Research and Development | |||||||||
Research and development is expensed as incurred. Research and development expenses for the years ended December 31, 2013 and 2012 were$19,408 and $68,372, respectively. | |||||||||
Shipping and Handling Costs | |||||||||
The Company classifies freight billed to customers as sales revenue and the related freight costs as cost of sales. | |||||||||
Revenue Recognition | |||||||||
The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products. | |||||||||
The Company meets these criteria upon shipment. | |||||||||
Expenses such as slotting fees and sales discounts are accounted for as a direct reduction of revenues as follows: | |||||||||
Year | Year | ||||||||
Ended | Ended | ||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Gross Sales | $ | 9,282,562 | $ | 4,948,254 | |||||
Less: Slotting, Discounts, Allowances | 540,941 | 365,409 | |||||||
Net Sales | $ | 8,741,621 | $ | 4,582,845 | |||||
Cost of sales | |||||||||
Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs. | |||||||||
Advertising | |||||||||
Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the years ended December 31, 2013 and 2012 were$2,440,424 and $1,460,000, respectively. | |||||||||
Stock-based compensation | |||||||||
The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Accounting for Stock-Based Compensation” (“ASC 718”) which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value based method of accounting for an employee stock option or similar equity instrument. The Company accounts for compensation cost for stock option plans in accordance with ASC 718. The Company accounts for share based payments to non-employees in accordance with ASC 505-50 “Accounting for Equity Instruments Issued to Non-Employees for Acquiring, or in Conjunction with Selling Goods or Services”. | |||||||||
The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. | |||||||||
Share based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the Statement of Operations. For the years ended December 31, 2013 and 2012 share based compensation amounted to $894,827 and $438,122, respectively.$731,894 of the $894,827 recorded for the year ended December 31, 2013 was a direct cost of a stock offering and has been recorded as a reduction in additional paid in capital. The $438,122 recorded for the year ended December 31, 2012 was a direct cost of a stock offering and has been recorded as a reduction in additional paid in capital. | |||||||||
For the year ended December 31, 2013, when computing fair value of share based payments, the Company has considered the following variables: | |||||||||
● | The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.68%-1.71%. | ||||||||
● | The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was $0. | ||||||||
● | The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. | ||||||||
● | The expected warrant term is the life of the warrant. | ||||||||
● | The expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 144%-193%. | ||||||||
● | The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%. | ||||||||
For the year ended December 31, 2012, when computing fair value of share based payments, the Company has considered the following variables: | |||||||||
● | The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.61%-1.01%. | ||||||||
● | The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was $0. | ||||||||
● | The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110.The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. | ||||||||
● | The expected warrant term is the life of the warrant. | ||||||||
● | Given the Company was privately held, expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 128%-147%. | ||||||||
● | The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%. | ||||||||
Earnings per share | |||||||||
Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss), adjusted for changes in income or loss that resulted from the assumed conversion of convertible shares, by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. | |||||||||
The Company had the following potential common stock equivalents at December 31, 2013: | |||||||||
Common stock subscribed | 533,333 | ||||||||
Common stock warrants, exercise price range of $1.00-$1.50 | 892,067 | ||||||||
Common stock options, exercise price of$1.00 | 428,845 | ||||||||
Total common stock equivalents | 1,854,245 | ||||||||
The Company had the following potential common stock equivalents at December 31, 2012: | |||||||||
Common stock warrants, exercise price of $1.00 | 505,400 | ||||||||
Common stock options, exercise price of $1.00 | 223,404 | ||||||||
Total common stock equivalents | 728,804 | ||||||||
Since the Company reflected a net loss during the years ended December 31, 2013 and 2012, the effect of considering any common stock equivalents, would have been anti-dilutive. A separate computation of diluted earnings (loss) per share is not presented. | |||||||||
Income Taxes | |||||||||
Income taxes are provided in accordance with ASC No. 740, Accounting for Income Taxes. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from the net change during the period of deferred tax assets and liabilities. | |||||||||
Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. | |||||||||
Recent accounting pronouncements | |||||||||
There are no recent accounting pronouncements that are expected to have an effect on the Company’s financial statements. |
Property_and_Equipment
Property and Equipment | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Property and Equipment | ' | ||||||||
Note 3 - Property and Equipment: | |||||||||
Property and equipment on December 31, 2013 and 2012 are as follows: | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Machinery and Equipment | $ | 982,017 | $ | 39,627 | |||||
982,017 | 39,627 | ||||||||
Less: Accumulated Depreciation | 52,521 | 22,176 | |||||||
$ | 929,496 | $ | 17,451 | ||||||
At December 31, 2013 machinery and equipment in the amount of $826,340 was not in service. | |||||||||
Depreciation expense charged to income for the years ended December 31, 2013 and 2012 amounted to $33,891 and $12,564 respectively. | |||||||||
During the year ended December 31, 2013, a vehicle with an original cost of $18,889 and adjusted basis of $15,343 was raffled off during a marketing & promotion campaign. |
Credit_Line
Credit Line | 12 Months Ended |
Dec. 31, 2013 | |
Debt Disclosure [Abstract] | ' |
Credit Line | ' |
Note 4 - Credit Line | |
On October 13, 2010 the Company signed a revolving note (the “Note”) with Provident Bank (the “Bank”) for $1,000,000. The available balance of this Note was reduced to $400,000 and extended to September 1, 2013. The outstanding balance accrues interest at a variable rate of 1.00% over the Wall Street Journal prime rate with a floor of 4.50% per annum. (Starting July 2013 the interest rate floor increased to 5%) Interest is payable monthly and the rate as of December 31, 2012 was 4.50%. | |
Advances are limited to 80% of eligible receivables (75 days from invoice) and 35% of finished goods inventory (Starting July 2013 advances are limited to 70% of eligible receivables). Inventory advances shall be capped at $250,000. Concentrations from any one customer exceeding 30% of total accounts receivable will be excluded from the borrowing base availability. The note is secured by accounts receivable, inventory, financial instruments, equipment, general intangibles and investment property and personal and unconditional guarantees of two of the shareholders of the Company. | |
The balance outstanding on the revolving note at December 31, 2013 and 2012 was $0 and $200,000, respectively. On September 9, 2013 the Note was repaid and cancelled. |
Investment_in_LLC
Investment in LLC | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Investments in and Advances to Affiliates, Schedule of Investments [Abstract] | ' | ||||||||
Investment in LLC | ' | ||||||||
Note 5- Investment in LLC | |||||||||
During 2011 the Company acquired a 34.62% interest in Meatball Obsession, LLC (“MO”) for a total investment of $27,032. This investment is accounted for using the equity method of accounting. Accordingly, investments are recorded at acquisition cost plus the Company’s equity in the undistributed earnings or losses of the entity. At December 31, 2011 the investment was brought down to $0 due to losses incurred by MO. | |||||||||
During 2012 the Company’s ownership interest in MO fell to 28% due to dilution. | |||||||||
During 2013 the Company’s ownership interest in MO fell to 15.8% due to dilution. | |||||||||
During the years ending December 31, 2013 and 2012, sales to MO were $85,541 and $73,768, respectively. At December 31, 2013 and 2012 the accounts receivable balance from MO was $1,457 and $12,680, respectively. | |||||||||
During 2013, the Company loaned MO $30,000 for working capital purposes. The loan was non-interest bearing, unsecured and due on June 19, 2013. The loan was paid in full on July 8, 2013. | |||||||||
Summarized financial information for Meatball Obsession, LLC is as follows: | |||||||||
Balance Sheet Data | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Assets | |||||||||
Cash | $ | 50,371 | $ | 117,777 | |||||
Accounts receivable | 7,895 | 5,234 | |||||||
Inventory | 11,417 | 14,935 | |||||||
Property & equipment, net | 165,398 | 75,861 | |||||||
Other assets | 51,368 | 60,370 | |||||||
Total Assets | $ | 286,449 | $ | 274,177 | |||||
Liabilities and Members’ Equity | |||||||||
Accounts payable | $ | 21,139 | $ | 25,731 | |||||
Other current liabilities | 28,480 | 8,354 | |||||||
Total Current Liabilities | 49,619 | 34,085 | |||||||
Members’ Equity | 236,830 | 240,092 | |||||||
Total Liabilities and Members’ Equity | $ | 286,449 | $ | 274,177 | |||||
Statement of Operations Data | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Revenues | $ | 566,354 | $ | 315,493 | |||||
Cost of goods sold | 220,672 | 129,571 | |||||||
Expenses | 794,648 | 534,961 | |||||||
Net operating loss | (448,966 | ) | (349,039 | ) | |||||
Other income (expenses) | (4,296 | ) | (1,988 | ) | |||||
Net loss | $ | (453,262 | ) | $ | (351,027 | ) |
Related_Party_Transactions
Related Party Transactions | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Related Party Transactions [Abstract] | ' | ||||||||
Related Party Transactions | ' | ||||||||
Note 6 - Related Party Transactions | |||||||||
Supply Agreement | |||||||||
On March 1, 2010, the Company entered into a five year agreement with a Manufacturer (the “Manufacturer”) who is a related party. The Manufacturer is owned by the CEO and President of the Company. Under the terms of the agreement, the Company grants to the Manufacturer a revocable license to use the Company’s recipes, formulas, methods and ingredients for the preparation and production of Company’s products, for manufacturing the Company’s product and all future improvements, modifications, substitutions and replacements developed by the Company. The Manufacturer in turn grants the Company the exclusive right to purchase the product. Under the terms of the agreement the Manufacturer agrees to manufacture, package, and store the Company’s products and the Company has the right to purchase products from one or more other manufacturers, distributors or suppliers. The agreement contains a perpetual automatic renewal clause for a period of one year after the expiration of the initial term. During the renewal period either party may cancel the contract with written notice nine months prior to the termination date. | |||||||||
Under the terms of the agreement if the Company specifies any change in packaging or shipping materials which results in the manufacturer incurring increased expense for packaging and shipping materials or in the Manufacturer being unable to utilize obsolete packaging or shipping materials in ordinary packaging or shipping, the Company agrees to pay as additional product cost the additional cost for packaging and shipping materials and to purchase at cost such obsolete packaging and shipping materials. If the Company requests any repackaging of the product, other than due to defects in the original packaging, the Company will reimburse the Manufacturer for any labor costs incurred in repackaging. Per the agreement, all product delivery shipping costs are the expense of the Company. | |||||||||
During the years ended December 31, 2013 and 2012, the Company purchased substantially all of it’s inventory from the Manufacturer. At December 31, 2013 and December 31, 2012, the Company has a deposit on inventory in the amount of $359,506 and $192,956, respectfully, to this Manufacturer. | |||||||||
Due from Manufacturer – related party | |||||||||
During years ended December 31, 2013 and 2012,the Manufacturer received payments on behalf of the Company for the Company’s customer invoices and the Manufacturer incurred expenses on behalf of the Company for shared administrative expenses and salary expenses. In addition the Company made several unsecured loans to the Manufacturer during 2013. The loan to the Manufacturer is unsecured, does not bear interest and is due on demand. At December 31, 2013 and 2012 the amount due from the Manufacturer is as follows: | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Customer receipts collected by Manufacturer on behalf of Company | $ | 575,255 | $ | 301,447 | |||||
Loan to Manufacturer | 450,000 | - | |||||||
Shared expenses paid by Manufacturer on behalf of the Company | (243,734 | ) | (142,247 | ) | |||||
Due from Manufacturer | $ | 781,521 | $ | 159,200 |
Concentrations
Concentrations | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Risks and Uncertainties [Abstract] | ' | |||||||||
Concentrations | ' | |||||||||
Note 7 - Concentrations | ||||||||||
Revenues | ||||||||||
For years ended December 31, 2013 and 2012, the Company had the following concentrations of revenues with customers: | ||||||||||
Customer | 31-Dec-13 | 31-Dec-12 | ||||||||
A | 14 | % | 15 | % | ||||||
B | 18 | % | 11 | % | ||||||
C | 17 | % | 35 | % | ||||||
D | 14 | % | 2 | % | ||||||
E | 9 | % | 14 | % | ||||||
Accounts Receivable | ||||||||||
As of December 31, 2013 and 2012, the Company had the following concentrations of accounts receivable with customers: | ||||||||||
Customer | 31-Dec-13 | 31-Dec-12 | ||||||||
A | 14 | % | 13 | % | ||||||
B | 16 | % | 30 | % | ||||||
C | 23 | % | 20 | % | ||||||
Cost of Sales | ||||||||||
For the years ended December 31, 2013 and 2012, the Company had the following concentrations of purchases from vendors: | ||||||||||
Vendor | 31-Dec-13 | 31-Dec-12 | ||||||||
A (Related Party) | 100 | % | 99 | % | ||||||
Stockholders_Equity
Stockholders' Equity | 12 Months Ended | ||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||
Equity [Abstract] | ' | ||||||||||||||||||
Stockholders' Equity | ' | ||||||||||||||||||
Note 8 - Stockholders’ Equity | |||||||||||||||||||
(A) Common Stock Transactions | |||||||||||||||||||
2012 | |||||||||||||||||||
The Company issued 5,054,000 shares for cash proceeds of $5,054,000 ($1.00/share). | |||||||||||||||||||
2013 | |||||||||||||||||||
As a result of the reverse merger (see Note 1) the Company had a deemed issuance of 800,000 shares of common stock. | |||||||||||||||||||
From July 1, 2013 through December 31, 2013, the Company issued 3,333,375 shares of common stock to investors in exchange for $5,000,000 in proceeds in connection with the private placement of the Company’s stock. | |||||||||||||||||||
Common stock subscribed | |||||||||||||||||||
In December 2013, the Company sold 533,333 shares of common stock to investors in exchange for $800,000 in proceeds in connection with the private placement of the Company’s stock. As of December 31, 2013 the shares had not been issued. | |||||||||||||||||||
In connection with the 2013 private placement the Company incurred fees of $1,604,000 consisting of $872,106 in cash and 386,666 warrants with a fair value of $731,894. | |||||||||||||||||||
(B) Options | |||||||||||||||||||
The following is a summary of the Company’s option activity: | |||||||||||||||||||
Options | Weighted Average Exercise Price | ||||||||||||||||||
Outstanding – January 01, 2012 | - | $ | - | ||||||||||||||||
Exercisable – January 01, 2012 | - | $ | - | ||||||||||||||||
Granted | 223,404 | $ | 1 | ||||||||||||||||
Exercised | - | $ | - | ||||||||||||||||
Forfeited/Cancelled | - | $ | - | ||||||||||||||||
Outstanding – December 31, 2012 | 223,404 | $ | 1 | ||||||||||||||||
Exercisable – December 31, 2012 | 223,404 | $ | 1 | ||||||||||||||||
Granted | 318,000 | $ | 1 | ||||||||||||||||
Exercised | - | $ | - | ||||||||||||||||
Forfeited/Cancelled | - | $ | - | ||||||||||||||||
Outstanding December 31, 2013 | 541,404 | $ | 1 | ||||||||||||||||
Exercisable – December 31, 2013 | 428,845 | $ | 1 | ||||||||||||||||
Options Outstanding | Options Exercisable | ||||||||||||||||||
Range of Exercise Price | Number Outstanding | Weighted Average Remaining Contractual Life (in years) | Weighted Average | Number | Weighted Average | ||||||||||||||
Exercise Price | Exercisable | Exercise Price | |||||||||||||||||
$ | 1 | 541,404 | 3.85 years | $ | 1 | 428,845 | $ | 1 | |||||||||||
At December 31, 2013 and December 31, 2012, the total intrinsic value of options outstanding and exercisable was $812,106 and $0, respectively. | |||||||||||||||||||
As of December 31, 2013, the Company has $90,931 in stock based compensation related to stock options that is yet to be vested. The weighted average expensing period of the unvested options is .8 years. | |||||||||||||||||||
(C) Warrants | |||||||||||||||||||
The following is a summary of the Company’s warrant activity: | |||||||||||||||||||
Warrants | Weighted Average Exercise Price | ||||||||||||||||||
Outstanding – January 01, 2012 | - | $ | - | ||||||||||||||||
Exercisable – January 01, 2012 | - | $ | - | ||||||||||||||||
Granted | 505,400 | $ | 1 | ||||||||||||||||
Exercised | - | $ | - | ||||||||||||||||
Forfeited/Cancelled | - | $ | - | ||||||||||||||||
Outstanding – December 31, 2012 | 505,400 | $ | 1 | ||||||||||||||||
Exercisable – December 31, 2012 | 505,400 | $ | 1 | ||||||||||||||||
Granted | 386,667 | $ | 1.5 | ||||||||||||||||
Exercised | - | $ | - | ||||||||||||||||
Forfeited/Cancelled | - | $ | - | ||||||||||||||||
Outstanding – December 31, 2013 | 892,067 | $ | 1.22 | ||||||||||||||||
Exercisable – December 31, 2013 | 892,067 | $ | 1.22 | ||||||||||||||||
Warrants Outstanding | Warrants Exercisable | ||||||||||||||||||
Range of | Number Outstanding | Weighted Average Remaining Contractual Life (in years) | Weighted Average | Number Exercisable | Weighted | ||||||||||||||
Exercise Price | Exercise Price | Average | |||||||||||||||||
Exercise Price | |||||||||||||||||||
$ | 1.00-$1.50 | 892,067 | 4.04 years | $ | 1.22 | 892,067 | $ | 1.22 | |||||||||||
At December 31, 2013 and December 31, 2012, the total intrinsic value of warrants outstanding and exercisable was $1,144,767 and $0, respectively. |
Commitments_and_Contingencies
Commitments and Contingencies | 12 Months Ended | ||||
Dec. 31, 2013 | |||||
Commitments and Contingencies Disclosure [Abstract] | ' | ||||
Commitments and Contingencies | ' | ||||
Note 9- Commitments and Contingencies | |||||
Litigations, Claims and Assessments | |||||
From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. The Company is currently not aware of any such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse effect on its business, financial condition or operating results. | |||||
Licensing and Royalty Agreements | |||||
On March 1, 2010, the Company was assigned a Development and License agreement (“the Agreement”). Under the terms of the Agreement the Licensor shall develop for the Company a line of beef meatballs with sauce, Italian sausage with sauce and other similar Italian meats with sauces for commercial manufacture, distribution and sale (each a “Licensor Product” and collectively the “Licensor Products”). Licensor shall work with Licensee to develop Licensor Products that are acceptable to Licensee. Upon acceptance of a Licensor Product by Licensee, Licensor’s trade secret recipes, formulas methods and ingredients for the preparation and production of such Licensor Products (the “Recipes”) shall be subject to this Development and License Agreement. | |||||
The term of the Agreement (the “Term”) shall consist of the Exclusive Term and the Non-Exclusive Term. The 12-month period beginning on each January 1 and ending on each December 31 is referred to herein as an “Agreement Year.” | |||||
The Exclusive Term began on January 1, 2009 (the “Effective Date”) and ends on the 50th anniversary of the Effective Date, unless terminated or extended as provided herein. Licensor, at its option, may terminate the Exclusive Term by notice in writing to Licensee, delivered between the 60th and the 90th day following the end of any Agreement Year if, on or before the 60th day following the end of such Agreement Year, Licensee has not paid Licensor Royalties with respect to such Agreement Year at least equal to the minimum royalty (the “Minimum Royalty”) for such Agreement Year. Subject to the foregoing sentence, and provided Licensee has not breached this Agreement and failed to cure such breach in accordance herewith, Licensee may extend the Exclusive Term for an additional twenty five (25) years, by notice in writing to Licensor, delivered on or before the 50th anniversary of the Effective Date. | |||||
The Non-Exclusive Term begins upon expiration of the Exclusive Term and continues indefinitely thereafter, until terminated by Licensor due to a material breach hereof by Licensee that remains uncured after notice and opportunity to cure in accordance herewith, or until terminated by Licensee. | |||||
Either party may terminate this Agreement in the event that the other party materially breaches its obligations and fails to cure such material breach within sixty (60) days following written notice from the non-breaching party specifying the nature of the breach. The following termination rights are in addition to the termination rights provided elsewhere in the agreement | |||||
● | Termination by Licensee - Licensee shall have the right to terminate this Agreement at any time on sixty (60) days written notice to Licensor. In such event, all moneys paid to Licensor shall be deemed non-refundable. | ||||
Under the terms of the Agreement the Company is required to pay quarterly royalty fees as follows: | |||||
During the Exclusive Term and the Non-Exclusive Term the Company will pay a royalty equal to the royalty rate (the “Royalty Rate”), multiplied by Company’s “Net Sales”. As used herein, “Net Sales” means gross invoiced sales of Products, directly or indirectly to unrelated third parties, less (a) discounts (including cash discounts), and retroactive price reductions or allowances actually allowed or granted from the billed amount (collectively “Discounts”); (b) credits, rebates, and allowances actually granted upon claims, rejections or returns, including recalls (voluntary or otherwise) (collectively, “Credits”); (c) freight, postage, shipping and insurance charges; (d) taxes, duties or other governmental charges levied on or measured by the billing amount, when included in billing, as adjusted for rebates and refunds; and (e) provisions for uncollectible accounts determined in accordance with reasonable accounting methods, consistently applied. | |||||
The Royalty Rate shall be: 6% of net sales up to $500,000 of net sales for each Agreement year; 4% of Net Sales from $500,000 up to $2,500,000 of Net Sales for each Agreement year; 2% of Net Sales from $2,500,000 up to $20,000,000 of Net Sales for each Agreement year; and 1% of Net Sales in excess of $20,000,000 of Net Sales for each Agreement year. | |||||
In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows: | |||||
Agreement Year | Minimum Royalty to be Paid with Respect to Such Agreement Year | ||||
1st and 2nd | $ | - | |||
3rd and 4th | $ | 50,000 | |||
5th, 6th and 7th | $ | 75,000 | |||
8th and 9th | $ | 100,000 | |||
10th and thereafter | $ | 125,000 | |||
The Company incurred $203,031 and $134,121 of royalty expenses for the years ended December 31, 2013 and 2012, respectively. Royalty expenses are included in general and administrative expenses on the Statement of Operations. | |||||
Agreements with Placement Agents and Finders | |||||
(A) December 1, 2011 | |||||
The Company entered into a Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective December 1, 2011 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $6 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”). | |||||
The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing. | |||||
Along with the above fees, the Company shall pay up to $40,000 for expenses incurred by Spartan in connection with this Financing, together with cost of background checks on the officers and directors of the Company. | |||||
During the year ended 2012 the Company paid to Spartan fees of $505,400 and issued Spartan 505,400 five year warrants with an exercise price of $1.00. | |||||
(B) May 2, 2013 | |||||
The Company entered into a second Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective May 2, 2013 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $5 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”). | |||||
The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and up to 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing. | |||||
The Company shall pay to Spartan a non-refundable monthly fee of $10,000 over a twelve to twenty four month period upon Spartan’s satisfaction of certain thresholds (raising of aggregate gross proceeds of $4.0mil-$5.0mil) outlined in the Spartan Advisory Agreement. On October 29, 2013 the Company entered into an amendment to the Agreement and the $10,000 monthly fee was cancelled. | |||||
During the year ended December 31, 2013 the Company paid to Spartan fees of $650,000 and issued Spartan 333,333 five year warrants with an exercise price of $1.50. | |||||
(C) October 22, 2013 | |||||
The Company entered into a third Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective October 22, 2013 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act, for a minimum of twenty-four months from the date of the agreement, as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $2.5 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”). | |||||
The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing. | |||||
The Company shall pay to Spartan a non-refundable monthly fee of $10,000 for the term of the agreement. Such monthly fee shall survive any termination of the Agreement. | |||||
During the year ended December 31, 2013 the Company paid to Spartan financing fees of $104,000 and issued Spartan 53,333 five year warrants with an exercise price of $1.50. | |||||
Supply Agreement | |||||
On October 3, 2011, the Company entered into a five year agreement with a non-related party manufacturer. Under the terms of the agreement, the Company grants to the manufacturer a revocable license to use the Company’s recipes, formulas, methods and ingredients for the preparation and production of Company’s products, for manufacturing the Company’s product and all future improvements, modifications, substitutions and replacements developed by the Company. The manufacturer in turn grants the Company the exclusive right to purchase the product. Under the terms of the agreement the manufacturer agrees to manufacture, package, and store the Company’s products and the Company has the right to purchase products from one or more other manufacturers, distributors or suppliers. The agreement contains a perpetual automatic renewal clause for additional periods of one year after the expiration of the initial term. During the renewal periods either party may cancel the contract with written notice nine months prior to the termination date. | |||||
Under the terms of the agreement if the Company specifies any change in packaging or shipping materials which results in the manufacturer incurring increased expense for packaging and shipping materials or in the manufacturer being unable to utilize obsolete packaging or shipping materials in ordinary packaging or shipping, the Company agrees to pay as additional product cost the additional cost for packaging and shipping materials and to purchase at cost such obsolete packaging and shipping materials. If the Company requests any repackaging of the product, other than due to defects in the original packaging, the Company will reimburse the manufacturer for any labor costs incurred in repackaging. Per the agreement all product delivery shipping costs are the expense of the Company. | |||||
Under the terms of the agreement, the Company is required to acquire and install production equipment at the manufacturer’s facility to be used solely for the manufacturing of the Company’s products. The manufacturer will bear all costs of operating and maintaining the production equipment during the period in which the manufacturer is manufacturing products pursuant to the agreement. The production equipment shall be owned by the Company. | |||||
In March 2012, the agreement was terminated and production equipment held by the manufacturer was returned to the Company. |
Income_Tax_Provision_Benefit
Income Tax Provision (Benefit) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Income Tax Disclosure [Abstract] | ' | ||||||||
Income Tax Provision (Benefit) | ' | ||||||||
Note 10 - Income Tax Provision (Benefit) | |||||||||
The income tax provision (benefit) consists of the following: | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Federal | |||||||||
Current | $ | - | $ | - | |||||
Deferred | (945,289 | ) | (599,149 | ) | |||||
State and Local | |||||||||
Current | - | - | |||||||
Deferred | (361,363 | ) | - | ||||||
Change in valuation allowance | 1,306,652 | 599,149 | |||||||
Income tax provision (benefit) | $ | - | $ | - | |||||
The Company has U.S. federal net operating loss carryovers (NOLs) of approximately $4.6M and $1.6M at December 31, 2013 and 2012, respectively, available to offset taxable income through 2033. If not used, these NOLs may be subject to limitation under Internal Revenue Code Section 382 should there be a greater than 50% ownership change as determined under the regulations. The Company plans on undertaking a detailed analysis of any historical and/or current Section 382 ownership changes that may limit the utilization of the net operating loss carryovers. The Company also has New Jersey State Net Operating Loss carry overs of $4.6M and $1.6M, as of December 31, 2013 and 2012, respectively, available to offset future taxable income through 2033. | |||||||||
In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon future generation for taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all the information available, Management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2013 and 2012, the change in the valuation allowance was $1,306,652 and $599,149. | |||||||||
The Company evaluated the provisions of ASC 740 related to the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740 prescribes a comprehensive model for how a company should recognize, present, and disclose uncertain positions that the Company has taken or expects to take in its tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the net benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits.” A liability is recognized (or amount of net operating loss carry forward or amount of tax refundable is reduced) for unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740. | |||||||||
If applicable, interest costs related to the unrecognized tax benefits are required to be calculated and would be classified as “Other expenses – Interest” in the statement of operations. Penalties would be recognized as a component of “General and administrative.” | |||||||||
No interest or penalties on unpaid tax were recorded during the years ended December 31, 2013 and 2012, respectively. As of December 31, 2013 and 2012, no liability for unrecognized tax benefits was required to be reported. The Company does not expect any significant changes in its unrecognized tax benefits in the next year. | |||||||||
The Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following: | |||||||||
Years Ended | |||||||||
Deferred Tax Assets | 31-Dec-13 | 31-Dec-12 | |||||||
Net operating loss carryovers | $ | 1,939,069 | $ | 599,149 | |||||
Total deferred tax assets | $ | 1,939,069 | $ | 599,149 | |||||
Valuation allowance | (1,905,801 | ) | (599,149 | ) | |||||
Deferred tax asset, net of valuation allowance | $ | 33,268 | $ | - | |||||
Deferred Tax Liabilities | |||||||||
Other deferred tax liabilities | (33,268 | ) | - | ||||||
Total deferred tax liabilities | $ | (33,268 | ) | $ | - | ||||
Net deferred tax asset (liability) | $ | - | $ | - | |||||
The expected tax expense (benefit) based on the statutory rate is reconciled with actual tax expense benefit as follows: | |||||||||
Year ended December 31, 2013 | Year ended December 31, 2012 | ||||||||
US Federal statutory rate | (34.00 | )% | (34.00 | )% | |||||
State income tax, net of federal benefit | (5.9 | ) | (5.9 | ) | |||||
Deferred tax true-up | (6.8 | ) | - | ||||||
Change in valuation allowance | 44.3 | 36.7 | |||||||
Other permanent differences | 2.4 | 3.2 | |||||||
Income tax provision (benefit) | - % | - % |
Subsequent_Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2013 | |
Subsequent Events [Abstract] | ' |
Subsequent Events | ' |
Note 11 - Subsequent Events | |
The Company has evaluated all events that occurred after the balance sheet date through the date when the consolidated financial statements were issued to determine if they must be reported. The Management of the Company determined that there were certain reportable subsequent events to be disclosed as follow. | |
Entry Into A Material Definitive Agreement | |
Effective January 3, 2014, MamaMancini’s Inc. (“Mama’s”) a Delaware corporation and wholly owned subsidiary of MamaMancini’s Holdings, Inc. (the “Company”), entered into a Sale and Security Agreement (the “Sale and Security Agreement”) with Faunus Group International, Inc. (“FGI”) to provide for a $1.5 million secured demand credit facility backed by its receivables and inventory (the “FGI Facility”). The Sale and Security Agreement has an initial three (3) year term (the “Original Term”) and shall be extended automatically for an additional one (1) year for each succeeding term unless written notice of termination is given by either party at least sixty (60) days prior to the end of the Original Term or any extension thereof. The Company and certain of its affiliates also entered into guarantees to guarantee the performance of the obligations under the Sale and Security Agreement (the “Guaranty Agreements”). Mama’s also granted FGI a security interest in and lien upon all of Mama’s right, title and interest in and to all of Mama’s Collateral (as defined in the Sale and Security Agreement). | |
Pursuant to the FGI Facility, FGI can elect to purchase eligible accounts receivables (“Purchased Accounts”) up to 70% of the value of such receivables (retaining a 30% reserve). At FGI’s election, FGI may advance Mama’s up to 70% of the value of any Purchased Accounts, subject to the FGI Facility. Reserves retained by FGI on any Purchased Accounts are expected to be refunded to Mama’s net of interest and fees on advances once the receivables are collected from customers. The interest rate on advances or borrowings under the FGI Facility will be the greater of (i) 6.75% per annum and (ii) 2.50% above the rate of interest designated by FGI as its selected “Prime Rate” or “Base Rate’, as the case may be (which as of the date hereof is based upon the Wall Street Journal, Money Rates Section). Any advances or borrowings under the FGI Facility are due on demand. | |
Mama’s also agreed to pay to FGI monthly collateral management fees of 0.42% of the average monthly balance of Purchased Accounts. The minimum monthly net funds employed during each contract year hereof shall be $500,000. Additionally, Mama’s paid FGI a one-time facility fee equal to 1% of the FGI Facility upon entry into the Sale and Security Agreement. | |
For further details please see the 8-K filed by the Company on January 10, 2014. | |
Change of year end | |
Effective January 13, 2014, MamaMancini’s Holdings, Inc. (the “Company”) changed its fiscal year-end date to January 31. The Company’s 2014 fiscal year shall commence on February 1, 2014 and conclude on January 31, 2015. The Company will file an Annual Report on Form 10-K for the year ended December 31, 2013 and will also file a transitional report with the United States Securities and Exchange Commission for the period of January 1, 2014 to January 31, 2014. | |
Unregistered Sale of Equity Securities | |
From January 1, 2014 through March 14, 2014, the Company issued 536,667 shares of common stock to investors in exchange for $805,000 in proceeds in connection with the private placement of the Company’s stock. The Company incurred approximately $104,650 in stock issuance costs in conjunction with the placement and issued Spartan 53,667 five year warrants with an exercise price of $1.50. |
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Policies) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Accounting Policies [Abstract] | ' | ||||||||
Principles of Consolidation | ' | ||||||||
Principles of consolidation | |||||||||
All significant intercompany accounts and transactions have been eliminated in consolidation. | |||||||||
Use of Estimates | ' | ||||||||
Use of estimates | |||||||||
The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for bad debt, inventory obsolescence, the fair value of share-based payments. | |||||||||
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates. | |||||||||
Risks and Uncertainties | ' | ||||||||
Risks and uncertainties | |||||||||
The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure. | |||||||||
The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including the general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis. | |||||||||
Cash | ' | ||||||||
Cash | |||||||||
The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at December 31, 2013 and December 31, 2012. | |||||||||
The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. | |||||||||
Accounts Receivable and Allowance for Doubtful Accounts | ' | ||||||||
Accounts receivable and allowance for doubtful accounts | |||||||||
Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of December 31, 2013 and 2012, the Company had reserves of $2,000. | |||||||||
Inventories | ' | ||||||||
Inventories | |||||||||
Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at December 31, 2013 and 2012: | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Finished goods | $ | 112,279 | $ | 76,570 | |||||
Property and Equipment | ' | ||||||||
Property and Equipment | |||||||||
Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives. | |||||||||
Asset lives for financial statement reporting of depreciation are: | |||||||||
Machinery and equipment | 2-7 years | ||||||||
Vehicles | 3-5 years | ||||||||
Fair Value of Financial Instruments | ' | ||||||||
Fair Value of Financial Instruments | |||||||||
For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short term financial instruments approximates fair value due to the relatively short period to maturity for these instruments. | |||||||||
Stock Issuance Costs | ' | ||||||||
Stock Issuance Costs | |||||||||
Stock Issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity. Offering costs recorded to equity for the years ended December 31, 2013 and 2012 were$1,604,000 and $1,088,964, respectively. | |||||||||
Research and Development | ' | ||||||||
Research and Development | |||||||||
Research and development is expensed as incurred. Research and development expenses for the years ended December 31, 2013 and 2012 were$19,408 and $68,372, respectively. | |||||||||
Shipping and Handling Costs | ' | ||||||||
Shipping and Handling Costs | |||||||||
The Company classifies freight billed to customers as sales revenue and the related freight costs as cost of sales. | |||||||||
Revenue Recognition | ' | ||||||||
Revenue Recognition | |||||||||
The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products. | |||||||||
The Company meets these criteria upon shipment. | |||||||||
Expenses such as slotting fees and sales discounts are accounted for as a direct reduction of revenues as follows: | |||||||||
Year | Year | ||||||||
Ended | Ended | ||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Gross Sales | $ | 9,282,562 | $ | 4,948,254 | |||||
Less: Slotting, Discounts, Allowances | 540,941 | 365,409 | |||||||
Net Sales | $ | 8,741,621 | $ | 4,582,845 | |||||
Cost of Sales | ' | ||||||||
Cost of sales | |||||||||
Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs. | |||||||||
Advertising | ' | ||||||||
Advertising | |||||||||
Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the years ended December 31, 2013 and 2012 were$2,440,424 and $1,460,000, respectively. | |||||||||
Stock-based Compensation | ' | ||||||||
Stock-based compensation | |||||||||
The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Accounting for Stock-Based Compensation” (“ASC 718”) which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value based method of accounting for an employee stock option or similar equity instrument. The Company accounts for compensation cost for stock option plans in accordance with ASC 718. The Company accounts for share based payments to non-employees in accordance with ASC 505-50 “Accounting for Equity Instruments Issued to Non-Employees for Acquiring, or in Conjunction with Selling Goods or Services”. | |||||||||
The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. | |||||||||
Share based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the Statement of Operations. For the years ended December 31, 2013 and 2012 share based compensation amounted to $894,827 and $438,122, respectively.$731,894 of the $894,827 recorded for the year ended December 31, 2013 was a direct cost of a stock offering and has been recorded as a reduction in additional paid in capital. The $438,122 recorded for the year ended December 31, 2012 was a direct cost of a stock offering and has been recorded as a reduction in additional paid in capital. | |||||||||
For the year ended December 31, 2013, when computing fair value of share based payments, the Company has considered the following variables: | |||||||||
● | The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.68%-1.71%. | ||||||||
● | The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was $0. | ||||||||
● | The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. | ||||||||
● | The expected warrant term is the life of the warrant. | ||||||||
● | The expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 144%-193%. | ||||||||
● | The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%. | ||||||||
For the year ended December 31, 2012, when computing fair value of share based payments, the Company has considered the following variables: | |||||||||
● | The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.61%-1.01%. | ||||||||
● | The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was $0. | ||||||||
● | The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110.The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. | ||||||||
● | The expected warrant term is the life of the warrant. | ||||||||
● | Given the Company was privately held, expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 128%-147%. | ||||||||
● | The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%. | ||||||||
Earnings Per Share | ' | ||||||||
Earnings per share | |||||||||
Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss), adjusted for changes in income or loss that resulted from the assumed conversion of convertible shares, by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. | |||||||||
The Company had the following potential common stock equivalents at December 31, 2013: | |||||||||
Common stock subscribed | 533,333 | ||||||||
Common stock warrants, exercise price range of $1.00-$1.50 | 892,067 | ||||||||
Common stock options, exercise price of$1.00 | 428,845 | ||||||||
Total common stock equivalents | 1,854,245 | ||||||||
The Company had the following potential common stock equivalents at December 31, 2012: | |||||||||
Common stock warrants, exercise price of $1.00 | 505,400 | ||||||||
Common stock options, exercise price of $1.00 | 223,404 | ||||||||
Total common stock equivalents | 728,804 | ||||||||
Since the Company reflected a net loss during the years ended December 31, 2013 and 2012, the effect of considering any common stock equivalents, would have been anti-dilutive. A separate computation of diluted earnings (loss) per share is not presented. | |||||||||
Income Taxes | ' | ||||||||
Income Taxes | |||||||||
Income taxes are provided in accordance with ASC No. 740, Accounting for Income Taxes. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from the net change during the period of deferred tax assets and liabilities. | |||||||||
Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. | |||||||||
Recent Accounting Pronouncements | ' | ||||||||
Recent accounting pronouncements | |||||||||
There are no recent accounting pronouncements that are expected to have an effect on the Company’s financial statements. |
Summary_of_Significant_Account2
Summary of Significant Accounting Policies (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Accounting Policies [Abstract] | ' | ||||||||
Schedule of Inventories | ' | ||||||||
Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at December 31, 2013 and 2012: | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Finished goods | $ | 112,279 | $ | 76,570 | |||||
Schedule of Property and Equipment Estimated Useful Lives | ' | ||||||||
Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives. | |||||||||
Asset lives for financial statement reporting of depreciation are: | |||||||||
Machinery and equipment | 2-7 years | ||||||||
Vehicles | 3-5 years | ||||||||
Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction | ' | ||||||||
Expenses such as slotting fees and sales discounts are accounted for as a direct reduction of revenues as follows: | |||||||||
Year | Year | ||||||||
Ended | Ended | ||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Gross Sales | $ | 9,282,562 | $ | 4,948,254 | |||||
Less: Slotting, Discounts, Allowances | 540,941 | 365,409 | |||||||
Net Sales | $ | 8,741,621 | $ | 4,582,845 | |||||
Schedule of Common Stock Equivalents | ' | ||||||||
The Company had the following potential common stock equivalents at December 31, 2013: | |||||||||
Common stock subscribed | 533,333 | ||||||||
Common stock warrants, exercise price range of $1.00-$1.50 | 892,067 | ||||||||
Common stock options, exercise price of$1.00 | 428,845 | ||||||||
Total common stock equivalents | 1,854,245 | ||||||||
The Company had the following potential common stock equivalents at December 31, 2012: | |||||||||
Common stock warrants, exercise price of $1.00 | 505,400 | ||||||||
Common stock options, exercise price of $1.00 | 223,404 | ||||||||
Total common stock equivalents | 728,804 |
Property_and_Equipment_Tables
Property and Equipment (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Schedule of Property, Plant and Equipment | ' | ||||||||
Property and equipment on December 31, 2013 and 2012 are as follows: | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Machinery and Equipment | $ | 982,017 | $ | 39,627 | |||||
982,017 | 39,627 | ||||||||
Less: Accumulated Depreciation | 52,521 | 22,176 | |||||||
$ | 929,496 | $ | 17,451 |
Investment_in_LLC_Tables
Investment in LLC (Tables) (Meatball Obsession, LLC [Member]) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Meatball Obsession, LLC [Member] | ' | ||||||||
Summary of Financial Information | ' | ||||||||
Summarized financial information for Meatball Obsession, LLC is as follows: | |||||||||
Balance Sheet Data | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Assets | |||||||||
Cash | $ | 50,371 | $ | 117,777 | |||||
Accounts receivable | 7,895 | 5,234 | |||||||
Inventory | 11,417 | 14,935 | |||||||
Property & equipment, net | 165,398 | 75,861 | |||||||
Other assets | 51,368 | 60,370 | |||||||
Total Assets | $ | 286,449 | $ | 274,177 | |||||
Liabilities and Members’ Equity | |||||||||
Accounts payable | $ | 21,139 | $ | 25,731 | |||||
Other current liabilities | 28,480 | 8,354 | |||||||
Total Current Liabilities | 49,619 | 34,085 | |||||||
Members’ Equity | 236,830 | 240,092 | |||||||
Total Liabilities and Members’ Equity | $ | 286,449 | $ | 274,177 | |||||
Statement of Operations Data | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Revenues | $ | 566,354 | $ | 315,493 | |||||
Cost of goods sold | 220,672 | 129,571 | |||||||
Expenses | 794,648 | 534,961 | |||||||
Net operating loss | (448,966 | ) | (349,039 | ) | |||||
Other income (expenses) | (4,296 | ) | (1,988 | ) | |||||
Net loss | $ | (453,262 | ) | $ | (351,027 | ) |
Related_Party_Transactions_Tab
Related Party Transactions (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Related Party Transactions [Abstract] | ' | ||||||||
Schedule of Amount Due from Manufacturer | ' | ||||||||
At December 31, 2013 and 2012 the amount due from the Manufacturer is as follows: | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Customer receipts collected by Manufacturer on behalf of Company | $ | 575,255 | $ | 301,447 | |||||
Loan to Manufacturer | 450,000 | - | |||||||
Shared expenses paid by Manufacturer on behalf of the Company | (243,734 | ) | (142,247 | ) | |||||
Due from Manufacturer | $ | 781,521 | $ | 159,200 |
Concentrations_Tables
Concentrations (Tables) | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Risks and Uncertainties [Abstract] | ' | |||||||||
Schedule of Revenue | ' | |||||||||
For years ended December 31, 2013 and 2012, the Company had the following concentrations of revenues with customers: | ||||||||||
Customer | 31-Dec-13 | 31-Dec-12 | ||||||||
A | 14 | % | 15 | % | ||||||
B | 18 | % | 11 | % | ||||||
C | 17 | % | 35 | % | ||||||
D | 14 | % | 2 | % | ||||||
E | 9 | % | 14 | % | ||||||
Schedule of Accounts Receivable | ' | |||||||||
As of December 31, 2013 and 2012, the Company had the following concentrations of accounts receivable with customers: | ||||||||||
Customer | 31-Dec-13 | 31-Dec-12 | ||||||||
A | 14 | % | 13 | % | ||||||
B | 16 | % | 30 | % | ||||||
C | 23 | % | 20 | % | ||||||
Schedule of Cost of Sales | ' | |||||||||
For the years ended December 31, 2013 and 2012, the Company had the following concentrations of purchases from vendors: | ||||||||||
Vendor | 31-Dec-13 | 31-Dec-12 | ||||||||
A (Related Party) | 100 | % | 99 | % | ||||||
Stockholders_Equity_Tables
Stockholders' Equity (Tables) | 12 Months Ended | ||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||
Equity [Abstract] | ' | ||||||||||||||||||
Summary of Option Activity | ' | ||||||||||||||||||
The following is a summary of the Company’s option activity: | |||||||||||||||||||
Options | Weighted Average Exercise Price | ||||||||||||||||||
Outstanding – January 01, 2012 | - | $ | - | ||||||||||||||||
Exercisable – January 01, 2012 | - | $ | - | ||||||||||||||||
Granted | 223,404 | $ | 1 | ||||||||||||||||
Exercised | - | $ | - | ||||||||||||||||
Forfeited/Cancelled | - | $ | - | ||||||||||||||||
Outstanding – December 31, 2012 | 223,404 | $ | 1 | ||||||||||||||||
Exercisable – December 31, 2012 | 223,404 | $ | 1 | ||||||||||||||||
Granted | 318,000 | $ | 1 | ||||||||||||||||
Exercised | - | $ | - | ||||||||||||||||
Forfeited/Cancelled | - | $ | - | ||||||||||||||||
Outstanding December 31, 2013 | 541,404 | $ | 1 | ||||||||||||||||
Exercisable – December 31, 2013 | 428,845 | $ | 1 | ||||||||||||||||
Summary of Option Outstanding and Exercisable | ' | ||||||||||||||||||
Options Outstanding | Options Exercisable | ||||||||||||||||||
Range of Exercise Price | Number Outstanding | Weighted Average Remaining Contractual Life (in years) | Weighted Average | Number | Weighted Average | ||||||||||||||
Exercise Price | Exercisable | Exercise Price | |||||||||||||||||
$ | 1 | 541,404 | 3.85 years | $ | 1 | 428,845 | $ | 1 | |||||||||||
Schedule of Warrants Activity | ' | ||||||||||||||||||
The following is a summary of the Company’s warrant activity: | |||||||||||||||||||
Warrants | Weighted Average Exercise Price | ||||||||||||||||||
Outstanding – January 01, 2012 | - | $ | - | ||||||||||||||||
Exercisable – January 01, 2012 | - | $ | - | ||||||||||||||||
Granted | 505,400 | $ | 1 | ||||||||||||||||
Exercised | - | $ | - | ||||||||||||||||
Forfeited/Cancelled | - | $ | - | ||||||||||||||||
Outstanding – December 31, 2012 | 505,400 | $ | 1 | ||||||||||||||||
Exercisable – December 31, 2012 | 505,400 | $ | 1 | ||||||||||||||||
Granted | 386,667 | $ | 1.5 | ||||||||||||||||
Exercised | - | $ | - | ||||||||||||||||
Forfeited/Cancelled | - | $ | - | ||||||||||||||||
Outstanding – December 31, 2013 | 892,067 | $ | 1.22 | ||||||||||||||||
Exercisable – December 31, 2013 | 892,067 | $ | 1.22 | ||||||||||||||||
Schedule of Warrants Outstanding and Exercisable | ' | ||||||||||||||||||
Warrants Outstanding | Warrants Exercisable | ||||||||||||||||||
Range of | Number Outstanding | Weighted Average Remaining Contractual Life (in years) | Weighted Average | Number Exercisable | Weighted | ||||||||||||||
Exercise Price | Exercise Price | Average | |||||||||||||||||
Exercise Price | |||||||||||||||||||
$ | 1.00-$1.50 | 892,067 | 4.04 years | $ | 1.22 | 892,067 | $ | 1.22 |
Commitments_and_Contingencies_
Commitments and Contingencies (Tables) | 12 Months Ended | ||||
Dec. 31, 2013 | |||||
Commitments and Contingencies Disclosure [Abstract] | ' | ||||
Schedule of Royalty Minimum Payment by Preceding Agreement Year | ' | ||||
In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows: | |||||
Agreement Year | Minimum Royalty to be Paid with Respect to Such Agreement Year | ||||
1st and 2nd | $ | - | |||
3rd and 4th | $ | 50,000 | |||
5th, 6th and 7th | $ | 75,000 | |||
8th and 9th | $ | 100,000 | |||
10th and thereafter | $ | 125,000 |
Income_Tax_Provision_Benefit_T
Income Tax Provision (Benefit) (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Income Tax Disclosure [Abstract] | ' | ||||||||
Scheudle of Provision For Income Tax | ' | ||||||||
The income tax provision (benefit) consists of the following: | |||||||||
31-Dec-13 | 31-Dec-12 | ||||||||
Federal | |||||||||
Current | $ | - | $ | - | |||||
Deferred | (945,289 | ) | (599,149 | ) | |||||
State and Local | |||||||||
Current | - | - | |||||||
Deferred | (361,363 | ) | - | ||||||
Change in valuation allowance | 1,306,652 | 599,149 | |||||||
Income tax provision (benefit) | $ | - | $ | - | |||||
Schedule of Deferred Tax Assets | ' | ||||||||
The Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following: | |||||||||
Years Ended | |||||||||
Deferred Tax Assets | 31-Dec-13 | 31-Dec-12 | |||||||
Net operating loss carryovers | $ | 1,939,069 | $ | 599,149 | |||||
Total deferred tax assets | $ | 1,939,069 | $ | 599,149 | |||||
Valuation allowance | (1,905,801 | ) | (599,149 | ) | |||||
Deferred tax asset, net of valuation allowance | $ | 33,268 | $ | - | |||||
Deferred Tax Liabilities | |||||||||
Other deferred tax liabilities | (33,268 | ) | - | ||||||
Total deferred tax liabilities | $ | (33,268 | ) | $ | - | ||||
Net deferred tax asset (liability) | $ | - | $ | - | |||||
Schedule of Reconciliation of Provision For Income Taxes | ' | ||||||||
The expected tax expense (benefit) based on the statutory rate is reconciled with actual tax expense benefit as follows: | |||||||||
Year ended December 31, 2013 | Year ended December 31, 2012 | ||||||||
US Federal statutory rate | (34.00 | )% | (34.00 | )% | |||||
State income tax, net of federal benefit | (5.9 | ) | (5.9 | ) | |||||
Deferred tax true-up | (6.8 | ) | - | ||||||
Change in valuation allowance | 44.3 | 36.7 | |||||||
Other permanent differences | 2.4 | 3.2 | |||||||
Income tax provision (benefit) | - % | - % |
Nature_of_Operations_and_Basis1
Nature of Operations and Basis of Presentation (Details Narrative) (USD $) | 0 Months Ended |
Jan. 24, 2013 | |
Nature Of Operations And Basis Of Presentation | ' |
Number of shares issued in exchange for acquisition | 20,054,000 |
Number of shares cancelled | 103,408,000 |
Aggregate amount paid in cancellation to majority shareholders | $295,000 |
Stock issued for consideration of common stock cancellation for majority shareholders | 800,000 |
Summary_of_Significant_Account3
Summary of Significant Accounting Policies (Details Narrative) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Accounting Policies [Abstract] | ' | ' |
Cash equivalents | $0 | $0 |
Accounts receivable reserves | 2,000 | 2,000 |
Stock offering cost recorded | 1,604,000 | 1,088,964 |
Research and development expense | 19,408 | 68,372 |
Advertising expenses | 2,440,424 | 1,460,000 |
Share based compensation | 894,827 | 438,122 |
Reduction in additional paid in capital | 731,894 | 438,122 |
Assumption risk-free interest rate of option in effect at the time of the grant minimum | 0.68% | 0.61% |
Assumption risk-free interest rate of option in effect at the time of the grant maximum | 1.71% | 1.01% |
Expected common stock dividend rate | $0 | $0 |
Expected volatility rate, minimum | 144.00% | 128.00% |
Expected volatility rate, maximum | 193.00% | 147.00% |
Historical forfeiture rate for unvested stock option | 0.00% | 0.00% |
Summary_of_Significant_Account4
Summary of Significant Accounting Policies - Schedule of Inventories (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
Accounting Policies [Abstract] | ' | ' |
Finished goods | $112,279 | $76,570 |
Summary_of_Significant_Account5
Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Lives (Details) | 12 Months Ended |
Dec. 31, 2013 | |
Minimum [Member] | Machinery And Equipment [Member] | ' |
Property and equipment estimated useful lives | '2 years |
Minimum [Member] | Vehicles [Member] | ' |
Property and equipment estimated useful lives | '3 years |
Maximum [Member] | Machinery And Equipment [Member] | ' |
Property and equipment estimated useful lives | '7 years |
Maximum [Member] | Vehicles [Member] | ' |
Property and equipment estimated useful lives | '5 years |
Summary_of_Significant_Account6
Summary of Significant Accounting Policies - Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Accounting Policies [Abstract] | ' | ' |
Gross Sales | $9,282,562 | $4,948,254 |
Less: Slotting, Discounts, Allowances | 540,941 | 365,409 |
Net Sales | $8,741,621 | $4,582,845 |
Summary_of_Significant_Account7
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details) | Dec. 31, 2013 | Dec. 31, 2012 |
Accounting Policies [Abstract] | ' | ' |
Common stock subscribed, shares | 533,333 | ' |
Common stock warrants, exercise price of $1.00- $1.50 | 892,067 | 505,400 |
Common stock options, exercise price of $1.00 | 428,845 | 223,404 |
Total common stock equivalents | 1,854,245 | 728,804 |
Summary_of_Significant_Account8
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details) (Parenthetical) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Common stock warrants, exercise price range | ' | $1 |
Common stock options, exercise price | $1 | $1 |
Minimum [Member] | ' | ' |
Common stock warrants, exercise price range | $1 | ' |
Maximum [Member] | ' | ' |
Common stock warrants, exercise price range | $1.50 | ' |
Property_and_Equipment_Details
Property and Equipment (Details Narrative) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Machinery and equipment | $826,340 | ' |
Depreciation expense | 33,891 | 12,564 |
Vehicle original cost | 982,017 | 39,627 |
Adjustment basis of marketing promotion campaign price | 15,343 | ' |
Vehicles [Member] | ' | ' |
Vehicle original cost | $18,889 | ' |
Property_and_Equipment_Schedul
Property and Equipment - Schedule of Property Plant and Equipment (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
Property, plant and equipment | $982,017 | $39,627 |
Less: Accumulated Depreciation | 52,521 | 22,176 |
Property, plant and equipment, net | 929,496 | 17,451 |
Machinery And Equipment [Member] | ' | ' |
Property, plant and equipment | $982,017 | $39,627 |
Credit_Line_Details_Narrative
Credit Line (Details Narrative) (USD $) | 0 Months Ended | 12 Months Ended | ||
Jul. 03, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Oct. 13, 2010 | |
Debt Disclosure [Abstract] | ' | ' | ' | ' |
Maximum limit of the notes outstanding balance | ' | ' | ' | $1,000,000 |
Note principal limited after reduction | ' | 400,000 | ' | ' |
Variable rate of accrued interest on the outstanding balance | ' | 1.00% | ' | ' |
Line of credit facility, floor rate | 5.00% | 4.50% | 4.50% | ' |
Monthly payable interest rate | ' | ' | 4.50% | ' |
Percentage of eligible receivables for which advances are limited | 70.00% | 80.00% | ' | ' |
Percentage of finished goods inventory for which advances are limited | ' | 35.00% | ' | ' |
Maximum limit for inventory advances | ' | ' | ' | 250,000 |
Customers exceeding thirty percent of the accounts receivables excluded from borrowing capacity | ' | 30.00% | ' | ' |
Line of credit, balance outstanding | ' | $0 | $200,000 | ' |
Investment_in_LLC_Details_Narr
Investment in LLC (Details Narrative) (USD $) | 0 Months Ended | 12 Months Ended | ||
Jul. 08, 2013 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | |
Reduction in investment due to losses in affiliates | ' | $0 | ' | ' |
Sales revenue | ' | ' | 8,741,621 | 4,582,845 |
Repayment of debt | 30,000 | ' | ' | ' |
Meatball Obsession, LLC [Member] | ' | ' | ' | ' |
Percentage of equity interest acquired in business combination | ' | 34.62% | ' | ' |
Total investment in Meatball Obsession, LLC | ' | 27,032 | ' | ' |
Reduction in ownership percentage | ' | ' | 15.80% | 28.00% |
Sales revenue | ' | ' | 85,541 | 73,768 |
Accounts receivable | ' | ' | 1,457 | 12,680 |
Loan to affiliates for working capital purpose | ' | ' | $30,000 | ' |
Loan due date | ' | ' | 19-Jun-13 | ' |
Summary_of_Financial_Informati
Summary of Financial Information (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Cash | $1,741,935 | $2,008,161 | $16,505 |
Accounts receivable | 1,063,849 | 463,565 | ' |
Inventory | 112,279 | 76,570 | ' |
Property & equipment, net | 929,496 | 17,451 | ' |
Total Assets | 5,124,111 | 2,982,081 | ' |
Total Current Liabilities | 823,044 | 529,233 | ' |
Members' Equity | 4,301,067 | 2,452,848 | 49,313 |
Total Liabilities and Members' Equity | 5,124,111 | 2,982,081 | ' |
Expenses | 5,489,994 | 3,339,532 | ' |
Net operating loss | -2,938,968 | -1,987,276 | ' |
Other income (expenses) | -8,640 | -12,347 | ' |
Net loss | -2,947,608 | -1,999,623 | ' |
Meatball Obsession, LLC [Member] | ' | ' | ' |
Cash | 50,371 | 117,777 | ' |
Accounts receivable | 7,895 | 5,234 | ' |
Inventory | 11,417 | 14,935 | ' |
Property & equipment, net | 165,398 | 75,861 | ' |
Other assets | 51,368 | 60,370 | ' |
Total Assets | 286,449 | 274,177 | ' |
Accounts payable | 21,139 | 25,731 | ' |
Other current liabilities | 28,480 | 8,354 | ' |
Total Current Liabilities | 49,619 | 34,085 | ' |
Members' Equity | 236,830 | 240,092 | ' |
Total Liabilities and Members' Equity | 286,449 | 274,177 | ' |
Revenues | 556,354 | 315,493 | ' |
Cost of goods sold | 220,672 | 129,571 | ' |
Expenses | 794,648 | 534,961 | ' |
Net operating loss | -448,966 | -349,039 | ' |
Other income (expenses) | -4,296 | -1,988 | ' |
Net loss | ($453,262) | ($351,027) | ' |
Related_Party_Transactions_Det
Related Party Transactions (Details Narrative) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
Related Party Transactions [Abstract] | ' | ' |
Deposit in inventory with manufacturer | $359,506 | $192,956 |
Related_Party_Transactions_Sch
Related Party Transactions - Schedule of Amount Due from Manufacturer (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Related Party Transactions [Abstract] | ' | ' |
Customer receipts collected by Manufacturer on behalf of Company | $575,255 | $301,447 |
Loan to Manufacturer | 450,000 | ' |
Shared expenses paid by Manufacturer on behalf of the Company | -243,734 | -142,247 |
Due from Manufacturer | $781,521 | $159,200 |
Concentrations_Schedule_of_Rev
Concentrations - Schedule of Revenue (Details) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Customer A [Member] | ' | ' |
Concentrations of Revenues | 14.00% | 15.00% |
Customer B [Member] | ' | ' |
Concentrations of Revenues | 18.00% | 11.00% |
Customer C [Member] | ' | ' |
Concentrations of Revenues | 17.00% | 35.00% |
Customer D [Member] | ' | ' |
Concentrations of Revenues | 14.00% | 2.00% |
Customer E [Member] | ' | ' |
Concentrations of Revenues | 9.00% | 14.00% |
Concentrations_Schedule_of_Acc
Concentrations - Schedule of Accounts Receivable (Details) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Customer A [Member] | ' | ' |
Concentration of Accounts Receivable | 14.00% | 13.00% |
Customer B [Member] | ' | ' |
Concentration of Accounts Receivable | 16.00% | 30.00% |
Customer C [Member] | ' | ' |
Concentration of Accounts Receivable | 23.00% | 20.00% |
Concentrations_Schedule_of_Pur
Concentrations - Schedule of Purchases From Major Vendors (Details) (Vendor A [Member]) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Vendor A [Member] | ' | ' |
A (Related Party) | 100.00% | 99.00% |
Stockholders_Equity_Details_Na
Stockholders' Equity (Details Narrative) (USD $) | 6 Months Ended | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Equity [Abstract] | ' | ' | ' | ' |
Proceeds from issuance of common stock | ' | $5,000,000 | $5,054,000 | ' |
Common stock issued cash, shares | ' | ' | 5,054,000 | ' |
Stock options exercise price | $1 | $1 | $1 | ' |
Issuance of common stock shares in reverse merger | ' | 800,000 | ' | ' |
Common stock shares issued in private placement | 3,333,375 | ' | ' | ' |
Proceed from common stock shares issued in private placement | 5,000,000 | ' | ' | ' |
Sold common shares | ' | 533,333 | ' | ' |
Common stock invetors in exchange | ' | 800,000 | ' | ' |
Stock issuance costs relating to private placement | 1,604,000 | ' | ' | ' |
Stock issuance consisting cash | ' | 872,106 | 650,842 | ' |
Number of warrants issued | ' | 386,666 | ' | ' |
Warrants issued for services | ' | 731,894 | 438,122 | ' |
Total intrinsic value of options outstanding and exercisable | 812,106 | 812,106 | 0 | ' |
Stock based compensation related to stock option | 90,931 | 90,931 | ' | ' |
Weighted average expensing period | ' | '8 years | ' | ' |
Total intrinsic value of warrants outstanding and exercisable | $1,144,767 | $1,144,767 | $0 | ' |
Stockholders_Equity_Summary_of
Stockholders' Equity - Summary of Option Activity (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Equity [Abstract] | ' | ' |
Options Outstanding, Beginning balance | 223,404 | ' |
Options, Granted | 318,000 | 223,404 |
Options, Exercised | ' | ' |
Options, Forfeited/Cancelled | ' | ' |
Options Outstanding, Ending balance | 541,404 | 223,404 |
Options Exercisable, Beginning balance | 223,404 | ' |
Options Exercisable, Ending balance | 428,845 | 223,404 |
Options Outstanding, Weighted Average Exercise Price, Beginning balance | $1 | ' |
Weighted Average Exercise Price, Granted | $1 | $1 |
Weighted Average Exercise Price, Exercised | ' | ' |
Weighted Average Exercise Price, Forfeited/Cancelled | ' | ' |
Options Outstanding, Weighted Average Exercise Price, Ending balance | $1 | $1 |
Options Exercisable, Weighted Average Exercise Price, Beginning balance | $1 | ' |
Options Exercisable, Weighted Average Exercise Price, Ending balance | $1 | $1 |
Stockholders_Equity_Summary_of1
Stockholders' Equity - Summary of Option Outstanding and Exercisable (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Equity [Abstract] | ' | ' | ' |
Range of exercise price | $1 | ' | ' |
Number of Options Outstanding | 541,404 | 223,404 | ' |
Weighted Average Remaining Contractual Life (in years), Options Outstanding | '3 years 10 months 6 days | ' | ' |
Weighted Average Exercise Price, Options Outstanding | $1 | $1 | ' |
Number of Options Exercisable | 428,845 | 223,404 | ' |
Weighted Average Exercise Price, Options Exercisable | $1 | $1 | ' |
Stockholders_Equity_Schedule_o
Stockholders' Equity - Schedule of Warrants Activity (Details) (Warrant [Member], USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Warrant [Member] | ' | ' |
Warrants Outstanding, Beginning balance | 505,400 | ' |
Warrants, Granted | 386,667 | 505,400 |
Warrants, Exercised | ' | ' |
Warrants, Forfeited/Cancelled | ' | ' |
Warrants Outstanding, Ending balance | 892,067 | 505,400 |
Warrants Exercisable, Begining balance | 505,400 | ' |
Warrants Exercisable, Ending balance | 892,067 | 505,400 |
Warrants Outstanding, Weighted Average Exercise Price, Beginning balance | $1 | ' |
Weighted Average Exercise Price, Granted | $1.50 | $1 |
Weighted Average Exercise Price, Exercised | ' | ' |
Weighted Average Exercise Price, Forfeited/Cancelled | ' | ' |
Warrants Outstanding, Weighted Average Exercise Price, Ending balance | $1.22 | $1 |
Warrants Exercisable, Weighted Average Exercise Price, Beginning balance | $1 | ' |
Warrants Exercisable, Weighted Average Exercise Price, Ending balance | $1.22 | $1 |
Schedule_of_Warrants_Outstandi
Schedule of Warrants Outstanding and Exercisable (Details) (Warrant [Member], USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Warrant [Member] | ' | ' | ' |
Range of exercise price, lower limit | $1 | ' | ' |
Range of exercise price, higher limit | $1.50 | ' | ' |
Number of Warrants Outstanding | 892,067 | ' | ' |
Weighted Average Remaining Contractual Life (in Years) | '4 years 15 days | ' | ' |
Weighted Average Exercise Price, Warrants Outstanding | $1.22 | ' | ' |
Number of Warrants Exercisable | 892,067 | 505,400 | ' |
Weighted Average Exercise Price, Warrants Exercisable | $1.22 | $1 | ' |
Commitments_and_Contingencies_1
Commitments and Contingencies (Details Narrative) (USD $) | 6 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||
Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 01, 2011 | Dec. 31, 2012 | 2-May-13 | 2-May-13 | Dec. 31, 2013 | Oct. 22, 2013 | Dec. 31, 2013 | Oct. 22, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | |
Advosory Agreement One [Member] | Advosory Agreement One [Member] | Advosory Agreement Two [Member] | Advosory Agreement Two [Member] | Advosory Agreement Two [Member] | Advosory Agreement Three [Member] | Advosory Agreement Three [Member] | Advosory Agreement Three [Member] | Year 1 [Member] | Year 2 [Member] | Year 2 [Member] | Year 3 [Member] | Year 3 [Member] | Year 4 [Member] | ||||
Spartan Capital Securities, LLC [Member] | Spartan Capital Securities, LLC [Member] | Spartan Capital Securities, LLC [Member] | Spartan Capital Securities, LLC [Member] | Maximum [Member] | Maximum [Member] | ||||||||||||
Percentage of royalty rate on net sales | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 6.00% | 4.00% | ' | 2.00% | ' | 1.00% |
Royalty net sales | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $500,000 | $500,000 | $2,500,000 | $2,500,000 | $20,000,000 | $20,000,000 |
Royalty expenses | ' | 203,031 | 134,121 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds form private placements | 5,000,000 | ' | ' | 6,000,000 | ' | 5,000,000 | ' | ' | 2,500,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Percentage of fee equal to aggregate gross proceeds | ' | ' | ' | 10.00% | ' | 10.00% | ' | 3.00% | 10.00% | 3.00% | ' | ' | ' | ' | ' | ' | ' |
Percentage of common stock issuable | ' | ' | ' | 10.00% | ' | 10.00% | ' | ' | 10.00% | ' | ' | ' | ' | ' | ' | ' | ' |
Payment of maximum amount paid for consideration of expenses incurred by Spartan | ' | ' | ' | ' | 40,000 | ' | ' | 10,000 | ' | 10,000 | ' | ' | ' | ' | ' | ' | ' |
Spartan fee paid amount | ' | ' | ' | ' | 505,400 | ' | ' | 650,000 | ' | 104,000 | ' | ' | ' | ' | ' | ' | ' |
Number of warrants issued | ' | 386,666 | ' | ' | 505,400 | ' | ' | 333,333 | ' | 53,333 | ' | ' | ' | ' | ' | ' | ' |
Warrants Remaining Contractual Life | ' | ' | ' | ' | '5 years | ' | ' | '5 years | ' | '5 years | ' | ' | ' | ' | ' | ' | ' |
Warrants exercise price | ' | ' | ' | ' | 1 | ' | ' | 1.5 | ' | ' | 1.5 | ' | ' | ' | ' | ' | ' |
Spartan advisory agreement description | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
The Company shall pay to Spartan a non-refundable monthly fee of $10,000 over a twelve to twenty four month period upon Spartan’s satisfaction of certain thresholds (raising of aggregate gross proceeds of $4.0 mil- $5.0 mil) outlined in the Spartan Advisory Agreement. | |||||||||||||||||
Fees cancellation on agreement amendment | ' | ' | ' | ' | ' | ' | ' | $10,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Commitments_and_Contingencies_2
Commitments and Contingencies - Schedule of Royalty Minimum Payment by Preceding Agreement Year (Details) (USD $) | 12 Months Ended |
Dec. 31, 2013 | |
Agreement Year 1st and 2nd [Member] | ' |
Minimum Royalty to be Paid | ' |
Agreement Year 3rd and 4th [Member] | ' |
Minimum Royalty to be Paid | 50,000 |
Agreement Year 5th, 6th and 7th [Member] | ' |
Minimum Royalty to be Paid | 75,000 |
Agreement Year 8th and 9th [Member] | ' |
Minimum Royalty to be Paid | 100,000 |
Agreement Year 10th and thereafter [Member] | ' |
Minimum Royalty to be Paid | $125,000 |
Income_Tax_Provision_Benefit_D
Income Tax Provision (Benefit) (Details Narrative) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Valuation allowance | $1,306,652 | $599,149 |
Domestic Tax Authority [Member] | ' | ' |
Net operating loss carryforward | 4,600,000 | 1,600,000 |
Net operating loss carry-forward expiration date | '2033 | ' |
New Jersey State [Member] | ' | ' |
Net operating loss carryforward | $4,600,000 | $1,600,000 |
Net operating loss carry-forward expiration date | '2033 | ' |
Income_Tax_Provision_Benefit_S
Income Tax Provision (Benefit) - Schedule of Provision for Income Taxes (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Income Tax Disclosure [Abstract] | ' | ' |
Federal current | ' | ' |
Federal deferred | -945,289 | -599,149 |
State and local current | ' | ' |
State and local deferred | -361,363 | ' |
Change in valuation allowance | 1,306,652 | 599,149 |
Income tax provision (benefit) | ' | ' |
Income_Tax_Provision_Benefit_S1
Income Tax Provision (Benefit) - Schedule of Deferred Tax Assets (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
Income Tax Disclosure [Abstract] | ' | ' |
Net operating loss carryovers | $1,939,069 | $599,149 |
Total deferred tax assets | 1,939,069 | 599,149 |
Valuation allowance | -1,905,801 | -599,149 |
Deferred tax asset, net of valuation allowance | 33,268 | ' |
Other deferred tax liabilities | -33,268 | ' |
Total deferred tax liabilities | -33,268 | ' |
Net deferred tax asset (liability) | ' | ' |
Income_Tax_Provision_Benefit_S2
Income Tax Provision (Benefit) - Schedule of Effective Income Tax Rate Reconciliation (details) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Income Tax Disclosure [Abstract] | ' | ' |
US Federal statutory rate | -34.00% | -34.00% |
State income tax, net of federal benefit | -5.90% | -5.90% |
Deferred tax true-up | -6.80% | ' |
Change in valuation allowance | 44.30% | 36.70% |
Other permanent differences | 2.40% | 3.20% |
Income tax provision (benefit) | ' | ' |
Subsequent_Events_Details_Narr
Subsequent Events (Details Narrative) (USD $) | 6 Months Ended | 12 Months Ended | 3 Months Ended | 0 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Mar. 14, 2014 | Mar. 14, 2014 | Jan. 03, 2014 | |
Subsequent Event [Member] | Subsequent Event [Member] | Faunus Group International, Inc [Member] | ||||
Spartan Capital Securities, LLC [Member] | Subsequent Event [Member] | |||||
Proceeds form private placements | $5,000,000 | ' | ' | ' | ' | $1,500,000 |
Purchase eligible percentage for account receivable | ' | ' | ' | ' | ' | 70.00% |
Balance percentage retain to reserve | ' | ' | ' | ' | ' | 30.00% |
Percentage of purchased accounts allow to advance | ' | ' | ' | ' | ' | 70.00% |
Per annum interest rate | ' | ' | ' | ' | ' | 6.75% |
Debt instrument, interest variable rate | ' | 1.00% | ' | ' | ' | 2.50% |
Debt instrument description | ' | ' | ' | ' | ' | ' |
Mama’s also agreed to pay to FGI monthly collateral management fees of 0.42% of the average monthly balance of Purchased Accounts. The minimum monthly net funds employed during each contract year hereof shall be $500,000. Additionally, Mama’s paid FGI a one-time facility fee equal to 1% of the FGI Facility upon entry into the Sale and Security Agreement. | ||||||
Minimum monthly net funds employee agreement | ' | ' | ' | ' | ' | 500,000 |
Common stock issued to investors, shares | ' | ' | 5,054,000 | 536,667 | ' | ' |
Common stock issued to investors | ' | 5,000,000 | 5,054,000 | 805,000 | ' | ' |
Stock issuance cost | ' | $1,604,000 | $1,088,964 | $104,650 | ' | ' |
Number of warrants issued | ' | 386,666 | ' | ' | 53,667 | ' |
Warrants exercise price | ' | ' | ' | ' | 1.5 | ' |